AI-and-human RCM, clinical documentation and value-based-care outsourcing for U.S. healthcare providers.
Price
Market Cap
Sector
Information Technology
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 8 | 8 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 221 | 368 | 501 | 622 | 811 | 1.2k | 2.2k | 1.8k |
| Borrowings | 0 | 62 | 53 | 43 | 227 | 77 | 766 | 110 |
| Other Liabilities | 141 | 62 | 133 | 154 | 101 | 101 | 600 | 265 |
| Total Liabilities | 370 | 500 | 704 | 836 | 1.2k | 1.4k | 3.6k | 2.2k |
| AssetsFixed Assets | 36 | 72 | 63 | 49 | 116 | 101 | 1.9k | 1.5k |
| CWIP | 0 | 0 | 0 | 0 | 0 | 10 | 2 | 0 |
| Investments | 5 | 16 | 16 | 19 | 473 | 734 | 361 | 10 |
| Other Assets | 329 | 412 | 624 | 767 | 567 | 560 | 1.4k | 653 |
| Total Assets | 370 | 500 | 704 | 836 | 1.2k | 1.4k | 3.6k | 2.2k |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (64.4×) and current (50.7×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 70.5% growth and a 51× exit, ₹1675 only delivers your return if you pay ₹13,368. The price is currently baking in 17% growth.
EPS grows 70.5%/yr for 5 years, then fades to 6% over 2, exits at 51×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 70.5% | 56.30 |
| FY28 | 70.5% | 95.99 |
| FY29 | 70.5% | 163.66 |
| FY30 | 70.5% | 279.05 |
| FY31 | 70.5% | 475.77 |
| FY32 | 38.2% ·fade | 657.75 |
| FY33 | 6.0% ·fade | 697.22 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.